Efficacy of a standardized cranberry supplement on overactive bladder symptoms and urobiome alterations in young women: a randomized, double-blind, placebo-controlled pilot trial
Frontiers in Cellular and Infection Microbiology · 2026
DOI: 10.3389/fcimb.2026.1952206 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Frontiers in Cellular and Infection Microbiology, 2026. Verfasst von Ayaka Ito und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, Kansai Medical University, Hirakata, Osaka, Japan. Hauptthemen laut MEDLINE: Dietary Supplements, Microbiota, Plant Extracts, Urinary Bladder, Overactive. Die Arbeit nennt 19 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Introduction
Urobiome dysbiosis has been implicated in the pathogenesis of overactive bladder (OAB). In this study, the efficacy of a cranberry supplement for OAB symptoms was investigated, and concurrent urobiome alterations were evaluated in young women.
Methods
This double-blind, randomized, placebo-controlled trial enrolled 26 women (median age, 23 years) with OAB (Overactive Bladder Symptom Score [OABSS] ≥ 3), who received either a cranberry supplement (36 mg proanthocyanidins per day) or placebo for 4 weeks. Clinical efficacy was assessed using the OABSS reduction rate, and urobiome composition was evaluated by 16S rRNA gene sequencing.
Results
Twenty-five participants were included in the analysis. At 4 weeks, the OABSS reduction rate was greater in the cranberry group than in the placebo group (median, 66.7% vs. 40.0%; p = 0.039). At baseline, the urobiome was dominated by Lactobacillus (median relative abundance, 64.2%). After cranberry supplementation, the relative abundance of Lactobacillus decreased within the cranberry group (median change, −4.39%; p = 0.027; q = 0.096). No compositional changes were observed in the placebo group.
Conclusions
Cranberry supplementation was associated with greater improvement in OAB symptoms than was observed with placebo in young women, while a decrease in Lactobacillus relative abundance was observed within the cranberry group. Given the small sample size of this exploratory pilot trial and the limited species-level resolution of 16S rRNA sequencing, these concurrent findings should be regarded as hypothesis-generating and warrant further investigation. Clinical trial registration https://www.umin.ac.jp/ctr/ , identifier UMIN000057544.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pediatrics, Kansai Medical University, Hirakata, Osaka, Japan.
- Clinical Training Center, Kansai Medical University, Hirakata, Osaka, Japan.
Zitieren
APA
Ito, A., Akagawa, S., Akagawa, Y., Tsuji, S., Kato, S., Yamanouchi, S., & Kaneko, K. (2026). Efficacy of a standardized cranberry supplement on overactive bladder symptoms and urobiome alterations in young women: a randomized, double-blind, placebo-controlled pilot trial. Frontiers in Cellular and Infection Microbiology. https://doi.org/10.3389/fcimb.2026.1952206
Vancouver
Ito A, Akagawa S, Akagawa Y, Tsuji S, Kato S, Yamanouchi S, et al. Efficacy of a standardized cranberry supplement on overactive bladder symptoms and urobiome alterations in young women: a randomized, double-blind, placebo-controlled pilot trial. Frontiers in Cellular and Infection Microbiology. 2026. doi:10.3389/fcimb.2026.1952206
BibTeX
@article{Ito2026,
author = {Ito, Ayaka and Akagawa, Shohei and Akagawa, Yuko and Tsuji, Shoji and Kato, Shogo and Yamanouchi, Sohsaku and Kaneko, Kazunari},
title = {Efficacy of a standardized cranberry supplement on overactive bladder symptoms and urobiome alterations in young women: a randomized, double-blind, placebo-controlled pilot trial},
journal = {Frontiers in Cellular and Infection Microbiology},
year = {2026},
doi = {10.3389/fcimb.2026.1952206}
}
EUVIMED